Skip to main content

genetic testing Archives

Study finds genetic screening of adults would be cost-effective

May. 9, 2023—A Vanderbilt analysis of population genetic testing concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.

Read more


Gene variants and transplant drug dose

May. 9, 2022—Genotyping multiple enzymes that metabolize the immunosuppressive drug tacrolimus — common used for lung transplant recipients — is important for correct dosing of the drug, Vanderbilt researchers found.

Read more


Studies combine genetic testing, electronic health records to find undiagnosed diseases

Apr. 28, 2022—Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations.

Read more


Study finds genetic testing useful for young AFib patients

Oct. 7, 2021—Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.

Read more


Initiative helps physicians interpret genetic test results

Sep. 1, 2021—A new institutional initiative will offer a secure and easy way for physicians at Vanderbilt University Medical Center to ask for help interpreting genetic test results for their patients.

Read more


Predictive model identifies patients for genetic testing

Jun. 3, 2021—Patients who, perhaps unbeknownst to their health care providers, are in need of genetic testing for rare undiagnosed diseases can be identified en masse based on routine information in electronic health records (EHRs), a research team reported June 3 in the journal Nature Medicine.

Read more


Diagnostic testing for genetic disorders now available on site

Mar. 12, 2020—Vanderbilt University Medical Center has opened a Clinical Genomics Laboratory to provide diagnostic testing for genetic disorders.

Read more


ACMG issues statement on breast cancer genetic testing

Jan. 16, 2020—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

Read more


The American College of Medical Genetics and Genomics advises evaluating all breast cancer patients to determine the need for genetic testing

Dec. 13, 2019—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

Read more


Study backs genetic testing for all metastatic breast cancer patients

Sep. 5, 2019—  by Tom Wilemon Genetic testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies, according to research published Aug. 29 in JAMA Oncology. In the study, 100 patients were tested regardless of whether they met the current National...

Read more


Study ‘ignites’ link between genes and drug response

Jul. 25, 2019—A national study is seeking to determine whether genetic testing can help physicians choose the best drugs for their patients to relieve pain and depression.

Read more


Personalized drug prescribing program expands, upgrades

Jan. 25, 2018—Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more